Latest Articles

Impostor syndrome is experienced by millions of people around the world cross culturally, and describes difficulty internalizing one's accomplishments or abilities, and instead attributing their success to other factors. In this article, we explore the prevalence of impostor syndrome in STEM and the impact it has on the scientific community.

Single-cell genomics methods, such as single cell RNA sequencing (scRNA-seq), involve labeling biomolecules originating from individual cells, therefore enabling high-throughput molecular analysis at single-cell resolution. This article explores the recent advances in single-cell genomics techniques, and the applications of such technologies.

At the British Neuroscience Association (BNA)’s Festival of Neuroscience, we were lucky enough to sit down with some influential neuroscientists to discuss their work. Here, we interview Lund University’s Professor Anders Björklund on his foundational research into the use of stem cell transplantation therapy for Parkinson’s disease.

Our reality is constructed through a combination of our sensory data. This process is called multisensory integration. In this article, neuroscientist Naomi Heffer outlines how exploring this process might help us understand how anxiety disorders affect our brain.

Mazes are an integral part of rodent behavioral research. In recent years, scientific data collected from maze studies have moved towards more cloud-based and electronic storage as opposed to traditional paper-based storage. In this article, we discuss modern mazes with Shuhan He, founder of maze developer MazeEngineers.com.

An international team of researchers has found a potential drug that may prevent neuronal death through glucose metabolism modification in stressed neurons.

We report the opening night of Biodesign Here Now, an event featuring architects, artists, textile designers, and many more creatives who have found ways to bring together biology and design in their work, showing a way forward for collaboration between the two fields.

In a bid to push personalized medicine forward, an ambitious ground-breaking £200 million project will see the 500,000 BioBank participants' whole genomes sequenced.

Failed drugs often are left on the shelf to gather dust. But sometimes, drugs can be dusted down and repurposed. That’s exactly the route that Katexco Pharmaceuticals has taken with its new immune system-targeting compounds, part of a new life sciences company that aims to target everything from multiple sclerosis to chronic pain.

At the British Neuroscience Association (BNA)’s Festival of Neuroscience , we sat down with some influential neuroscientists to discuss their work. Here, we interview University College London Professor Uta Frith on her pioneering work into the neurodevelopmental condition autism spectrum disorder.